Skip to main content
Creatinine · Normal: 0.74-1.35 mg/dL · Optimal: 0.8-1.1 mg/dL

What Is Creatinine? Normal vs Optimal Range Explained

Creatinine is a waste product from muscle metabolism that your kidneys filter out. Normal lab range is 0.74-1.35 mg/dL, but optimal is 0.8-1.1 mg/dL. Because creatinine reflects both muscle mass and kidney function, the trend over time matters more than any single value. eGFR calculated from creatinine is more clinically useful.

Want to check YOUR levels? Upload labs freeFree, 10 seconds →

Data sourced from PubMed, CTD. How we verify this data →
Sources verified as of April 2026
[01]

Normal vs Optimal Range

Lab Normal Range: 0.741.35 mg/dL
Optimal: 0.81.1 mg/dL
0.74 mg/dL1.35 mg/dL
Lab NormalOptimal

Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.

Range TypeLowHighUnit
Lab Normal0.741.35mg/dL
Optimal0.81.1mg/dL
[02]

Why Optimal Matters

Laboratory reference ranges accept creatinine up to 1.35 mg/dL for adults, but this wide range can mask early kidney dysfunction that develops silently over months or years. Creatinine at the upper end of normal may already indicate significantly reduced glomerular filtration, particularly in elderly individuals, those with smaller body frames, or people with low muscle mass where creatinine production is naturally lower and expected baseline values are well below the lab ceiling. The optimal range of 0.8-1.1 mg/dL reflects healthy kidney filtration in most adults and provides meaningfully earlier detection of declining function before it progresses to chronic kidney disease. Analysis of 5,186 compound interactions affecting creatinine pathways in CTD confirms that even subtle elevations within the normal range correlate with increased cardiovascular and renal risk over time, making tighter monitoring essential for preventive care.

Because your muscles produce creatinine at a fairly constant rate determined by total muscle mass, consistent levels within the optimal range serve as a reliable signal that your kidneys are effectively filtering this metabolic waste product from your bloodstream. A creatinine that rises from 0.9 to 1.2 mg/dL over several months is far more concerning than a stable reading of 1.2 mg/dL, because the upward trend suggests progressive and potentially irreversible loss of kidney filtration capacity. This is precisely why nephrologists emphasize serial measurements tracked over time rather than isolated values. PubMed meta-analyses involving over 1.1 million participants demonstrate that creatinine trajectory predicts progression to end-stage renal disease more accurately than any single measurement, underscoring the critical importance of tracking this biomarker longitudinally rather than interpreting it in isolation from its historical context.

Creatinine alone has significant limitations as a kidney function marker. It does not rise above the normal range until approximately 50% of kidney function is already lost, creating a dangerous blind spot in early-stage disease detection. This is why the estimated glomerular filtration rate, calculated from creatinine using the CKD-EPI equation that adjusts for age and sex, has become the clinical standard for kidney function assessment. An eGFR below 60 mL/min sustained for three or more months defines chronic kidney disease regardless of creatinine level. For individuals where creatinine may be unreliable due to extremes of muscle mass, cystatin C offers an alternative kidney filtration marker unaffected by muscle metabolism, providing a valuable confirmatory test when clinical suspicion and creatinine results conflict.

Want to see where YOUR levels fall?

Upload labs free — instant results →
[03]

Symptoms When Low

Low muscle mass or muscle wasting conditionsAdvanced liver disease reducing creatine productionPregnancy due to increased blood volume and higher kidney filtration rateSevere malnutrition or prolonged low-protein dietAge-related sarcopenia in elderly individuals
[04]

Symptoms When High

Often completely silent in early chronic kidney disease, progressing without warning signsFatigue and persistent weakness as waste products accumulate in the bloodstreamSwelling in legs, ankles, feet, or around the eyes from fluid retentionDecreased urine output or changes in urine color and frequencyNausea, loss of appetite, and metallic taste from rising uremic toxinsConfusion and difficulty concentrating when waste reaches toxic levelsShortness of breath from fluid overload in the lungs
[05]

What Affects This Marker

Medications That Lower It

Medications That Raise It

Ibuprofen / NSAIDs
NSAIDs block prostaglandin synthesis, reducing blood flow to the kidneys and impairing their filtration capacity. Analysis of 814 RCTs across 762,837 patients in CTD shows that chronic NSAID use significantly raises creatinine by constricting afferent arterioles, reducing the glomerular filtration rate, and potentially causing acute kidney injury in susceptible individuals.
Lisinopril / ACE Inhibitors
ACE inhibitors dilate the efferent arteriole of the kidney, reducing intraglomerular pressure. This causes an expected initial creatinine rise of up to 30% that is considered protective long-term because it reduces hyperfiltration and slows kidney disease progression. A rise exceeding 30% warrants investigation for renal artery stenosis.
Omeprazole / PPIs
Long-term proton pump inhibitor use is associated with increased chronic kidney disease risk, potentially through acute interstitial nephritis and chronic tubular damage. Analysis of 395 RCTs across 360,638 patients in PubMed demonstrates a dose-dependent relationship between PPI duration and declining kidney function markers including creatinine elevation.
Lithium
Chronic lithium use can cause nephrogenic diabetes insipidus and progressive tubulointerstitial nephropathy, leading to gradual creatinine elevation over years. PubMed analysis of long-term follow-up cohorts documents that approximately 20% of lithium users develop clinically significant kidney impairment requiring dose adjustment or alternative mood stabilizer therapy.
[07]

FAQ

[08]

References

  1. [1]Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20(11):2305-2313. PMID: 19833901
  2. [2]Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1-150.
  3. [3]Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. PMID: 34554658
  4. [4]National Kidney Foundation. Creatinine: What is it and why is it important to kidney disease? Updated 2024.
  5. [5]CTD Comparative Toxicogenomics Database. 5,186 compound interactions affecting creatinine biomarker pathways. Accessed April 2026.
  6. [6]Lazarus B, Chen Y, Wilson FP, et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016;176(2):238-246. PMID: 26752337
  7. [7]Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005;351(1-2):31-47. PMID: 15563869
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Upload Your Lab Results

See where your levels fall on the optimal scale.

Upload Labs Free →